Hepoer, a pharmaceutical company in Zhongshan's National Health Technology Park, launched the "Bo Lin Lan" generic isosulfan blue product for injection on December 6, filling a gap in the field of domestic solid tumor surgery.
Hepoer settled in the National Health Technology Park in Torch Development Zone in 2013. It has an R&D center in Shanghai's Zhangjiang Science City, and has established a strategic partnership with Sun Yat-sen University. Supported by the Zhongshan government in terms of customized workshop construction, policies, sci-tech services, CDMO platforms, the company has obtained more than 20 invention patents at home and abroad.
"We aim to put 5 or 6 innovative drug products into the clinical stage every year, hoping to make contributions to the high-quality development of Zhongshan's industries," said Hepoer chairman Shi Min.
Police?Registration?Number:?44200002442868
Website?ID:?4420000052
Sponsored?by:??Office?of?Zhongshan?Municipal?People's?Government
Technical?Support:???Information?Center?of?Zhongshan
Without?written?authorization?from??Zhongshan?Municipal?People’s?Government,?the?content?of?the?site?shall?not?be?republished?or?used?in?any?form.
About Us | Site Map| Privacy Statement| Contact us